ZIOPHARM Oncology, Inc. (ZIOP) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
Loss from operations: -10.91M
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Loss from operations: -10.91M
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q3 EPS of ($0.01), $0.23 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $120 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c
- Greenlane Holdings Inc. (GNLN) reported Q2 result
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
